IRCT138812083446N1
Completed
Phase 2
Determining the effect of selenium supplement on inflammatory, oxidative and nutritional markers in hemodialysis patients
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- End stage renal disease.
- Sponsor
- Shiraz university of medical sciences
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •being on dialysis at least 2\-3 sessions per week for 3 months, age range of 17\-85 years. Exclusion criteria: being admitted in hospital during last month, having active infection, using multivitamins or immunosupressive drugs, being pregnant.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effect of selenium on malnutrition- inflamation complex syndrome (MICS) in hemodialysis patientsEnd stage renal disease , hemodialysis.Chronic renal failureIRCT138812043408N1Shiraz University of Medical Sciences80
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Completed
Phase 3
Selenium supplementation in the treatment of hemodialysis patientsIRCT20170513033941N62Islamic Azad University40
Completed
Phase 3
Determining the effect of Selenium supplementation on CD4+ T lymphocyte count in HIV+ patients refered to Iranian HIV/AIDS Research Center (IRCHA)HIV infection.Unspecified human immunodeficiency virus [HIV] diseaseIRCT138904244380N2Vice Chancellor For Research, Tehran University of Medical Sciences100